Başlıksız Belge
| September 28, 2017 - Thursday |
| |
| 08:30 - 09:00 |
Opening Ceremony & Presidential Address
Serdar Turhal
Mahmut Gümüş
|
| |
| 09:00 - 10:00 |
Round Table Discussion (ESMO Members & Young Oncologists) Improving standards in oncology practice through educational collaboration
Chair: Pınar Saip |
| 09:00 - 09:05 |
ESMO representative address
Pınar Saip
|
| 09:05 - 09:20 |
ESMO point of view
Adrian-Radu Vidra, Romania
|
| 09:20 - 09:40 |
Young oncologists point of view
Ece Esin
|
| 09:40 - 10:00 |
Q’s & A’s and Discussion |
| |
| 10:00 - 10:15 |
Coffee Break |
| |
| 10:15 - 12:00 |
Round Table Discussion
Bridging ways to implement clinical trials and translational research in our region
Moderator: Ahmet Demirkazık (President, Turkish Oncology Research Group)
|
Panelists:
Erdem Göker (Academic), Turkey
Serdar Turhal (Academic), Turkey
Giampaolo Tortora (ESMO representative), Italy
Raphael Catane, Israel
Nia Sharikadze, Georgia
Elif Coşkunçay, BMS, Turkey
Ersen Gökser, Association of Research-Based Pharmaceutical Companies, Turkey
Elif İnci Somuncuoğlu (Ministry of Health, Turkish Medicines and Medical Devices Agency, Turkey |
| |
| 12:00 - 13:00 |
Lunch |
| |
| 13:00 - 15:00 |
Tumor immunology and novel immunotherapy approaches in malignant melanoma and non-melanoma skin tumors
Chairs: Müge Akmansu, Semra Paydaş
|
| 13:00 - 13:20 |
Recent advances on immune checkpoint inhibition in melanoma and non-melanoma skin tumors
Faysal Dane
|
| 13:20 - 13:40 |
Novel immunotherapy approaches in advanced melanoma with chemotherapy combinations and oncolytic viruses
Hüseyin Abalı
|
| 13:40 - 14:00 |
The emerging role of abscopal irradiation in immunotherapy
Fazilet Dinçbaş
|
| 14:00 - 14:20 |
Novel strategies to overcome immune checkpoint resistance
Başak Oyan Uluç
|
| 14:20 - 14:40 |
Monitoring and management for immune checkpoint-related toxicity
Burçak Karaca
|
| 14:40 - 15:00 |
Discussion |
| |
| 15:00 - 15:20 |
Coffee Break |
| |
| 15:20 - 16:20 |
Pro-Con Discussion: Long and winding road to implement personalized treatment in oncology
Chairs: Erdem Göker, Hüseyin Baloğlu
|
| 15:20 - 15:40 |
Predictive multi-gene panels should be used in the decision making process for all patients with metastatic cancer
Arturo Loaiza – Bonilla, USA
|
| 15:40 - 16:00 |
Multi-gene genomic analysis to select treatment is not feasible and genetic biomarkers should be limited to mutation-driven tumors
Fuat Demirelli
|
| 16:00 - 16:20 |
Discussion |
| |
| 16:20 - 17:00 |
Oral Abstracts
Chairs: Ertuğrul Seyrek, İlhan Öztop
Discussant: Tülay Akman
|
| |
| 17:00 - 19:30 |
Opening Reception |
| September 29, 2017 - Friday |
| |
| 08:30 - 10:20 |
Perspectives in the management for early stage non-small cell lung cancer
Chairs: Ethem Oral, Şükrü Dilege
|
| Pro-Con Session: Surgery versus SBRT |
Surgery
Serhan Tanju
|
SBRT
Hale Çağlar
|
| Discussion |
Role of emerging biomarkers and new pathologic classifiers in the selection of patients for adjuvant chemotherapy
Pınar Fırat
|
Optimal use of systemic therapy in the neoadjuvant & adjuvant setting: a practical approach
Fatih Köse
|
| Discussion |
| |
| 10:20 - 10:40 |
Coffee Break |
| |
| 10:40 - 11:40 |
Keynote Lecture
Chair: Fulden Yumuk
|
Recent developments and novel strategies to improve current immunotherapeutic approaches in non-small cell lung cancer
Jan van Meerbeeck, Belgium |
| |
| 11:40 - 13:00 |
Mutation-driven non-small cell lung cancer
Chairs: Hakan Bozcuk, Dilek Yılmazbayhan
|
| 11:40 - 12:00 |
Optimal use of liquid biopsies in the management for mutation-driven NSCLC
Büge Öz
|
| 12:00 - 12:20 |
Optimal sequencing of EGFR targeted therapy
Sema Sezgin Göksu
|
| 12:20 - 12:40 |
Novel agents and sequencing of therapy for ALK, ROS 1 and rare mutations
Nuri Karadurmuş
|
| 12:40 - 13:00 |
Discussion |
| |
| 13:00 - 14:00 |
Lunch |
| |
| 14:00 - 14:40 |
Oral Abstracts
Chairs: Hasan Şenol Coşkun, Özlem Er
Discussant: Metin Şeker
|
| |
| 14:40 - 16:40 |
The evolution of early stage breast cancer management
Chairs: Necati Özen, Handan Onur
|
| 14:40 - 15:00 |
A glimpse to the past
Cemalettin Topuzlu
|
| 15:00 - 15:20 |
Evolution of surgical management for breast cancer in the modern era
Cihan Uras
|
| 15:20 - 15:40 |
A modern approach to systemic treatment for early stage breast cancer
Gül Başaran
|
| 15:40 - 16:00 |
Optimal use of adjuvant radiotherapy in the context of de-escalated surgical management for early breast cancer
Ferah Yıldız
|
| 16:00 - 16:20 |
Role of neo-adjuvant chemotherapy for the management of operable breast cancer
Raphael Catane
|
| 16:20 - 16:40 |
Discussion |
| |
| 16:40 - 17:00 |
Coffee Break |
| |
| 17:00 - 18:20 |
Advances in the management of metastatic breast cancer
Chairs: Yavuz Özışık, Asif Abasov, Azerbaijan
|
| 17:00 - 17:20 |
The morphologic landscape of breast cancer and novel targets
Ayşegül Şahin, USA
|
| 17:20-17:40 |
Changing algorithms for the management of endocrine responsive metastatic breast cancer
Carlos H. Barrios, Brasil
|
| 17:40-18:00 |
Is there a new hope on the horizon for triple negative breast cancer?
Banu Arun, USA
|
| 18:00 - 18:20 |
Discussion |
| |
| 18:20 |
Adjourn |
| September 30, 2017 - Saturday |
| |
| 09:00 - 10:20 |
Novel treatment strategies in gynecologic oncology
Chairs: Sinan Berkman, Nilüfer Güler
|
| 09:00 - 09:20 |
Role of HIPEC in epithelial ovarian cancer
Nejat Özgül
|
| 09:20 - 09:40 |
Is there a role for sentinel lymph node biopsy in gynecologic cancers?
Cem İyibozkurt
|
| 09:40 - 10:00 |
Novel targets and precision medicine for gynecologic tumors
Ömer Dizdar
|
| 10:00 - 10:20 |
Discussion |
| |
| 10:20 - 10:40 |
Coffee Break |
| |
| 10:40 - 12:30 |
Recent advances in management strategies of upper gastrointestinal cancers
Chairs: Abdullah Zorluoğlu, Deniz Yalman
|
| 10:40 - 11:00 |
Optimal use of surgery and standards in lymph node dissection for the management of esophageal and esophago-gastric junction tumors
Emre Balık
|
| 11:00 - 11:20 |
Role of neoadjuvant chemo-radiation for upper GI adenocarcinoma
Deniz Yalman
|
| 11:20 - 11:40 |
Role of neo-adjuvant and adjuvant therapy following surgery in upper GI carcinomas
Gökhan Demir
|
| 11:40 - 12:00 |
Novel targets and advances in systemic treatment for upper GI carcinomas
Sylvie Lorenzen
|
| 12:00 - 12:20 |
Discussion |
| |
| 12:20 - 13:30 |
Lunch |
| |
| 13:30 - 14:30 |
Industrial Symposium
Ramucirumab; New Standard in Gastric Cancer
2nd Line Treatment
Chair: Faruk Aykan
Lecturer: Sylvie Lorenzen, Germany
|
 |
| |
| 14:30 - 15:40 |
Emerging data for the management of colorectal cancer
Chairs: Faruk Aykan, Mert Saynak
|
| 14:30 - 14:50 |
Omission of surgery in rectal cancer following neoadjuvant treatment and follow-up strategies
Yusif Aliyerov, Azerbeijan
|
| 14:50 - 15:10 |
Impact of tumor site in choice of systemic treatment for metastatic colorectal cancer
Mehmet Artaç
|
| 15:10 - 15:30 |
Novel agents and sequencing of systemic treatment for metastatic colorectal cancer
Mutlu Doğan
|
| 15:30 - 15:50 |
Discussion |
| |
| 15:50 - 16:10 |
Coffee Break |
| |
| 16:10 - 17:30 |
New horizons in radio-embolization treatment of hepatic malignancies
Chairs: Murat Cantaşdemir, Cüneyt Türkmen
|
| 16:10 - 16:30 |
Radioembolization in the treatment of HCC; from palliative to curative options
Murat Cantaşdemir
|
| 16:30 - 16:50 |
Recent advances in overall survival & response rate of Radioembolization in liver tumors
Cüneyt Türkmen
|
| 16:50 - 17:10 |
Integrating Radioembolization to Chemo & Immunotherapy in metastatic liver disease
Yeşim Yıldırım
|
| 17:10 - 17:30 |
Discussion |
| |
| 17:30 - 18:30 |
Poster Discussion
Chair: İrfan Çiçin
|
|
Discussant: Özlem Sönmez
|
| |
| 18:30 |
Adjourn |
| October 1, 2017 - Sunday |
| |
| 09:30 – 12:00 |
TSMO – TUBA – UICC Joint Session
Panel Discussion:
Maintaining a value-based care model in the era of increasing pressures towards individualized treatment
Moderators:
Tezer Kutluk, UICC, Union for International Cancer Control, Turkey
Taner Demirer, TUBA, Turkish Academy of Sciences, Turkey
|
| 09:30 – 09:45 |
The global framework that is shaping national strategies
Cary Adams, CEO, UICC, Union for International Cancer Control, Switzerland
|
| 09:45 – 10:00 |
Perspectives and learning from national efforts to optimize access to cancer detection, diagnosis, treatment and care
Richard Sullivan Institute of Cancer Policy, King’s College London, United Kingdom
|
| 10:00 – 10:15 |
Value-based cancer care: perspectives for the practicing oncologist
Yeşim Eralp, MD, Istanbul University Institute of Oncology, Turkey
|
| 10:15 – 11:45 |
Discussion with regional representatives:
Azad Kerimli, Chief Oncologist, Ministry of Health of the Republic of Azerbaijan, Azerbaijan
Necati Alkış, Director, Dr. Abdurrahman Yurtaslan Research and Training Hospital, Turkey
Ido Wolf, Director, Tel Aviv Sourasky Medical Center, Israel
Tamari Rukhadze, Vice-Dean of Faculty of Medicine at Iv. Javakhishvili Tbilisi State University, Georgia
Ahmet Özet, President, National Cancer Institute, Turkey
Engin Tutkun, Bozok University, Department of Public Health, Turkey
Hossein Madani, Iran
Nariman Tabynbayev, Kazakhstan
|
| 11:45 – 12:00 |
Concluding remarks
Tezer Kutluk, UICC
|
| |
| 12:00 – 12:15 |
Farewell remarks
Yeşim Eralp
|
|
| |
|
|
|
|
| |
|